advertisement

---

Sgambellone S 16

Showing records 1 to 16 | Display all abstracts from Sgambellone S

122419 Histamine H receptor antagonist/nitric oxide donors as novel promising therapeutic hybrid-tools for glaucoma and retinal neuroprotection
Sgambellone S
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2024; 180: 117454

---

120751 Lasamide Containing Sulfonylpiperazines as Effective Agents for the Management of Glaucoma Associated Symptoms
Kilbile JT
ChemMedChem 2024; 19: e202400601

---

122419 Histamine H receptor antagonist/nitric oxide donors as novel promising therapeutic hybrid-tools for glaucoma and retinal neuroprotection
Khanfar MA
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2024; 180: 117454

---

120751 Lasamide Containing Sulfonylpiperazines as Effective Agents for the Management of Glaucoma Associated Symptoms
Sapkal SB; Renzi G
ChemMedChem 2024; 19: e202400601

---

122419 Histamine H receptor antagonist/nitric oxide donors as novel promising therapeutic hybrid-tools for glaucoma and retinal neuroprotection
Marri S
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2024; 180: 117454

---

120751 Lasamide Containing Sulfonylpiperazines as Effective Agents for the Management of Glaucoma Associated Symptoms
D'Agostino I
ChemMedChem 2024; 19: e202400601

---

122419 Histamine H receptor antagonist/nitric oxide donors as novel promising therapeutic hybrid-tools for glaucoma and retinal neuroprotection
Villano S
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2024; 180: 117454

---

120751 Lasamide Containing Sulfonylpiperazines as Effective Agents for the Management of Glaucoma Associated Symptoms
Boudjelal M
ChemMedChem 2024; 19: e202400601

---

122419 Histamine H receptor antagonist/nitric oxide donors as novel promising therapeutic hybrid-tools for glaucoma and retinal neuroprotection
Nardini P
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2024; 180: 117454

---

120751 Lasamide Containing Sulfonylpiperazines as Effective Agents for the Management of Glaucoma Associated Symptoms
Tamboli Y
ChemMedChem 2024; 19: e202400601

---

122419 Histamine H receptor antagonist/nitric oxide donors as novel promising therapeutic hybrid-tools for glaucoma and retinal neuroprotection
Frank A
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2024; 180: 117454

---

120751 Lasamide Containing Sulfonylpiperazines as Effective Agents for the Management of Glaucoma Associated Symptoms
Cutarella L
ChemMedChem 2024; 19: e202400601

---

122419 Histamine H receptor antagonist/nitric oxide donors as novel promising therapeutic hybrid-tools for glaucoma and retinal neuroprotection
Reiner-Link D; Stark H
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2024; 180: 117454

---

120751 Lasamide Containing Sulfonylpiperazines as Effective Agents for the Management of Glaucoma Associated Symptoms
Mori M; Sgambellone S
ChemMedChem 2024; 19: e202400601

---

122419 Histamine H receptor antagonist/nitric oxide donors as novel promising therapeutic hybrid-tools for glaucoma and retinal neuroprotection
Lucarini L
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2024; 180: 117454

---

120751 Lasamide Containing Sulfonylpiperazines as Effective Agents for the Management of Glaucoma Associated Symptoms
Villano S; Marri S; Lucarini L; Carradori S; Carta F; Supuran CT
ChemMedChem 2024; 19: e202400601

---